SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subrecipients: where the money went next
13 subawards totaling $5.24M (54.2% of what was obligated), as University of Southern California reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMERS DISEASE BIOBANKS
2023-01-20
Curii Corporation
$684.9K
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMERS DISEASE BIOBANKS
2024-06-13
Curii Corporation
$684.3K
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMERS DISEASE BIOBANKS
2025-02-14
Curii Corporation
$683.0K
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMERS DISEASE BIOBANKS
2026-04-02
Trustees of Boston University
$328.6K
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMER’S DISEASE BIOBANKS
2026-05-27
Trustees of the University of Pennsylvania, the
$327.1K
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMER’S DISEASE BIOBANKS
2026-04-01
Trustees of the University of Pennsylvania, the
$327.1K
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMER’S DISEASE BIOBANKS
Every action
12 actions since 2022-11-02. Each is a modification or amendment with the money it added or took back.
Date
Amendment
Kind
Amount
What the agency wrote
2026-06-18
003
Revision
$0
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMERS DISEASE BIOBANKS - ABSTRACT IN RESPONSE TO PAR-19-269 “COGNITIVE SYSTEMS ANALYSIS OF ALZHEIMER'S DISEASE GENETIC AND PHENOTYPIC DATA (U01 CLINICAL TRIAL NOT ALLOWED)”, OUR PROJECT UNITES EXPERTS…
2026-02-27
002
Revision
$0
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMERS DISEASE BIOBANKS - ABSTRACT IN RESPONSE TO PAR-19-269 “COGNITIVE SYSTEMS ANALYSIS OF ALZHEIMER'S DISEASE GENETIC AND PHENOTYPIC DATA (U01 CLINICAL TRIAL NOT ALLOWED)”, OUR PROJECT UNITES EXPERTS…
2026-02-10
001
Continuation
$2.56M
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMERS DISEASE BIOBANKS - ABSTRACT IN RESPONSE TO PAR-19-269 “COGNITIVE SYSTEMS ANALYSIS OF ALZHEIMER'S DISEASE GENETIC AND PHENOTYPIC DATA (U01 CLINICAL TRIAL NOT ALLOWED)”, OUR PROJECT UNITES EXPERTS…
2026-02-02
000
Revision
$0
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMERS DISEASE BIOBANKS - ABSTRACT IN RESPONSE TO PAR-19-269 “COGNITIVE SYSTEMS ANALYSIS OF ALZHEIMER'S DISEASE GENETIC AND PHENOTYPIC DATA (U01 CLINICAL TRIAL NOT ALLOWED)”, OUR PROJECT UNITES EXPERTS…
2025-08-20
001
Revision
$0
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMERS DISEASE BIOBANKS - ABSTRACT IN RESPONSE TO PAR-19-269 “COGNITIVE SYSTEMS ANALYSIS OF ALZHEIMER'S DISEASE GENETIC AND PHENOTYPIC DATA (U01 CLINICAL TRIAL NOT ALLOWED)”, OUR PROJECT UNITES EXPERTS…
2025-03-19
000
Revision
$0
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMERS DISEASE BIOBANKS - ABSTRACT IN RESPONSE TO PAR-19-269 “COGNITIVE SYSTEMS ANALYSIS OF ALZHEIMER'S DISEASE GENETIC AND PHENOTYPIC DATA (U01 CLINICAL TRIAL NOT ALLOWED)”, OUR PROJECT UNITES EXPERTS…
2024-09-05
001
Revision
$0
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMERS DISEASE BIOBANKS - ABSTRACT IN RESPONSE TO PAR-19-269 “COGNITIVE SYSTEMS ANALYSIS OF ALZHEIMER'S DISEASE GENETIC AND PHENOTYPIC DATA (U01 CLINICAL TRIAL NOT ALLOWED)”, OUR PROJECT UNITES EXPERTS…
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗
2026-04-28
Trustees of Indiana University
$319.0K
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMER’S DISEASE BIOBANKS
2026-06-02
University of Maryland, College Park
$309.2K
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMER’S DISEASE BIOBANKS
2026-04-01
Northern California Institute for Research and Education, Inc.
$308.5K
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMER’S DISEASE BIOBANKS
2026-04-13
The Trustees of Columbia University in the City of New York
$69.0K
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMER’S DISEASE BIOBANKS
2026-05-05
University of Washington
$65.2K
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMER’S DISEASE BIOBANKS
2026-04-04
University of Pittsburgh - of the Commonwealth System of Higher Education
$62.2K
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMER’S DISEASE BIOBANKS
2024-08-22
000
Continuation
$3.35M
ULTRASCALE MACHINE LEARNING TO EMPOWER DISCOVERY IN ALZHEIMERS DISEASE BIOBANKS - ABSTRACT IN RESPONSE TO PAR-19-269 “COGNITIVE SYSTEMS ANALYSIS OF ALZHEIMER'S DISEASE GENETIC AND PHENOTYPIC DATA (U01 CLINICAL TRIAL NOT ALLOWED)”, OUR PROJECT UNITES EXPERTS…
2023-08-25
003
Revision
$357.5K
BENCHMARKING AND COMPARING AD-RELATED AI METHODS ACROSS SITES ON A STANDARDIZED DATASET - ABSTRACT IN RESPONSE TO PAR-19-269 “COGNITIVE SYSTEMS ANALYSIS OF ALZHEIMER'S DISEASE GENETIC AND PHENOTYPIC DATA (U01 CLINICAL TRIAL NOT ALLOWED)”, OUR PROJECT UNITES…
2023-08-18
002
Continuation
$3.39M
BENCHMARKING AND COMPARING AD-RELATED AI METHODS ACROSS SITES ON A STANDARDIZED DATASET - ABSTRACT IN RESPONSE TO PAR-19-269 “COGNITIVE SYSTEMS ANALYSIS OF ALZHEIMER'S DISEASE GENETIC AND PHENOTYPIC DATA (U01 CLINICAL TRIAL NOT ALLOWED)”, OUR PROJECT UNITES…
2023-08-18
001
Revision
$0
BENCHMARKING AND COMPARING AD-RELATED AI METHODS ACROSS SITES ON A STANDARDIZED DATASET - ABSTRACT IN RESPONSE TO PAR-19-269 “COGNITIVE SYSTEMS ANALYSIS OF ALZHEIMER'S DISEASE GENETIC AND PHENOTYPIC DATA (U01 CLINICAL TRIAL NOT ALLOWED)”, OUR PROJECT UNITES…
2022-11-02
000
Revision
$0
BENCHMARKING AND COMPARING AD-RELATED AI METHODS ACROSS SITES ON A STANDARDIZED DATASET - ABSTRACT IN RESPONSE TO PAR-19-269 “COGNITIVE SYSTEMS ANALYSIS OF ALZHEIMER'S DISEASE GENETIC AND PHENOTYPIC DATA (U01 CLINICAL TRIAL NOT ALLOWED)”, OUR PROJECT UNITES…
U01AG068057: Ultrascale Machine Learning to Empower Discovery in Alzheimers… · SpendQuery